Opendata, web and dolomites

Cell2Cell SIGNED

What makes a successfull pathogen? Understanding the impact of cell-to-cell heterogeneity in chromatin structure on infection and adaptation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Cell2Cell project word cloud

Explore the words cloud of the Cell2Cell project. It provides you a very rough idea of what is the project "Cell2Cell" about.

host    hypothesized    challenged    cellular    lasting    establishment    revolutionize    chromatin    elucidation    infections    sequence    unicellular    understand    genomics    enormous    skilled    people    genome    cancer    academia    individual    serve    technologies    biology    infectious    variability    microbial    train    multicellular    modern    organization    heterogeneity    decades    outcome    structural    limitations    cell    establishing    noise    evade    models    demands    give    mechanisms    small    prepared    single    revealed    plays    developmental    changing    signal    pathogens    industry    enabled    of    cell2cell    yeast    plasticity    dna    size    little    immune    millions    overcome    burden    epigenetic    pathogen    stage    decrease    previously    endeavor    lack    genetic    barriers    environments    population    molecular    insights    experts    adapt    diseases    renders    species    scientists    bioinformatics    successful    kill    organisms    worldwide    started    phenotypic    employ    degree    caused    tools    proposes    unveiling    infection   

Project "Cell2Cell" data sheet

The following table provides information about the project.

Coordinator
LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN 

Organization address
address: GESCHWISTER SCHOLL PLATZ 1
city: MUENCHEN
postcode: 80539
website: www.uni-muenchen.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 3˙889˙769 €
 EC max contribution 3˙889˙769 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2019
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN DE (MUENCHEN) coordinator 1˙011˙153.00
2    HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH DE (NEUHERBERG) participant 505˙576.00
3    THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD UK (OXFORD) participant 303˙172.00
4    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
5    SCHWEIZERISCHES TROPEN- UND PUBLIC HEALTH-INSTITUT CH (Basel) participant 281˙276.00
6    INSTITUT CURIE FR (PARIS) participant 274˙802.00
7    STICHTING KATHOLIEKE UNIVERSITEIT NL (NIJMEGEN) participant 265˙619.00
8    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) participant 263˙500.00
9    INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES PT (LISBOA) participant 237˙720.00
10    EPIGENETIKS GENETIK BIYOINFORMATIK YAZILIM AS TR (ISTANBUL) participant 235˙248.00
11    CELLSORTER MUSZAKI KUTATO ES FEJLESZTO KFT HU (BUDAPEST) participant 229˙715.00

Map

 Project objective

Infectious diseases kill millions of people worldwide every year. Decades of research have revealed important insights into the molecular mechanisms pathogens employ to establish lasting infections, yet little is known about what renders individual pathogens within a microbial population more successful at establishing an infection than others. Recent advances in single-cell technologies have started to revolutionize modern biology, unveiling an enormous degree of cell-to-cell heterogeneity. Often, phenotypic variability is not caused by genetic changes in the DNA sequence, but by epigenetic changes in the structural organization of DNA called chromatin. In multicellular organisms, this epigenetic plasticity plays a key role in developmental processes and cancer. In unicellular pathogens, cell-to-cell heterogeneity is hypothesized to promote the establishment of infections by allowing the pathogen to adapt to changing environments or evade the host immune response. To decrease the burden of infectious diseases, it is therefore, necessary to better understand how infections are enabled by cellular heterogeneity at the chromatin level of the pathogen. Several limitations have previously challenged this endeavor, including small genome size (i.e. low signal-to-noise) and the lack of knowledge of how chromatin is organized in pathogens. Cell2Cell proposes to overcome these barriers by bringing together (1) experts in pathogen biology; (2) the use of unicellular yeast species to serve as chromatin models; (3) single-cell technologies; (4) bioinformatics tools. Using state of the art technologies, we will train early stage researchers to identify the molecular mechanisms that control cell-to-cell heterogeneity in pathogens. The proposed research will contribute to the elucidation of how heterogeneity affects the outcome of diseases and give rise to highly skilled scientists that are well prepared to face the demands of modern genomics research in academia and industry.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CELL2CELL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CELL2CELL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

SAMCAPS (2018)

Self-Assembled MicroCAPSules: Synthesis, Characterization, and Eco-friendly Application in Home Care Products

Read More  

INSPIRE (2020)

INnovation in Safety Pharmacology for Integrated cardiovascular safety assessment to REduce adverse events and late stage drug attrition.

Read More  

CHANGE (2019)

Cultural Heritage Analysis for New GEnerations

Read More